Skip to main content
kneu
Request a demo

References

  1. 1.Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M, Murray C. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255–265. Link
  2. 2.Pearson C, Hartzman A, Munevar D, Feeney M, Dolhun R, Todaro V, Rosenfeld S, Willis A, Beck JC. Care access and utilization among medicare beneficiaries living with Parkinson’s disease. NPJ Parkinsons Dis. 2023 Jul 10;9(1):108. Link
  3. 3.Alzheimer’s Association. 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 2020. Link
  4. 4.Dementia: Assessment, management and support for people living with dementia and their carers. London: National Institute for Health and Care Excellence (NICE); 2018 Jun. (NICE Guideline, No. 97.) 8, Inpatient care. Link
  5. 5.Alzheimer’s Association. 2025 Alzheimer’s disease facts and figures: Special report – American perspectives on early detection of Alzheimer’s disease in the era of treatment. Link
  6. 6.Chen Y, Bandosz P, Stoye G, Liu Y, Wu Y, Lobanov-Rostovsky S, French E, Kivimaki M, Livingston G, Liao J, Brunner EJ. Dementia incidence trend in England and Wales, 2002-19, and projection for dementia burden to 2040: analysis of data from the English Longitudinal Study of Ageing. Lancet Public Health. 2023 Nov;8(11):e859-e867. Link
  7. 7.Kneu Health. Service evaluation with data provided by clinicians.
  8. 8.Unless referenced otherwise, figures in this section are from a Kneu Health service evaluation with data provided by clinicians.
  9. 9.Kneu Health. Data from East Suffolk and North Essex NHS Foundation Trust, contract period from December 2023.
  10. 10.Calculations based on independent economic modelling by Corevitas and Health Innovation East. Includes outpatient efficiencies, inpatient non-elective savings and A&E savings for Parkinson’s Disease.
  11. 11.NHS England. Bed availability and occupancy statistics (KH03). Link
  12. 12.Calculations based on RTM billing CPT 98975, 98977, 98980 / 98981 for engaged patients, and a subset of these identified for review & management each month.
  13. 13.Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Parkinsons Dis. 2018;8(s1):S3-S8. Link
  14. 14.Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T. Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025 Mar 5;388:e080952. Link
  15. 15.Public Health England (2021) Health matters: midlife approaches to reduce dementia risk. UK Government. Link
  16. 16.Velandia PP, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, Tsakalos G, Wimo A, Dieleman JL. Global and regional spending on dementia care from 2000-2019 and expected future health spending scenarios from 2020-2050: An economic modelling exercise. EClinicalMedicine. 2022. Link